NCT05602428View on ClinicalTrials.gov

Analysis of Clinical Effect of Subanesthetic Dose of Esketamine Combined With Hip Capsule Peripheral Nerve Block in Elderly Patients Undergoing Total Hip Arthroplasty

NACompletedINTERVENTIONAL
Enrollment

120

Participants

Timeline

Start Date

January 1, 2020

Primary Completion Date

May 31, 2021

Study Completion Date

May 31, 2021

Conditions
Total Hip Arthroplasty
Interventions
DRUG

esketamine sub-anesthetic,

the use of esketamine sub-anesthetic dose combined with hip capsule peripheral nerve block

DRUG

esketamine sub-anesthetic

Esketamine subanesthetic dose combined with lumbar plexus block was used

DRUG

esketamine sub-anesthetic

general anesthesia was performed with esketamine subanesthetic dose.

Trial Locations (1)

213000

ChangzhouTCMH, Changzhou

All Listed Sponsors
lead

Changzhou Traditional Chinese Medicine Hospital Affiliated to Nanjing University of Chinese Medicine

OTHER

NCT05602428 - Analysis of Clinical Effect of Subanesthetic Dose of Esketamine Combined With Hip Capsule Peripheral Nerve Block in Elderly Patients Undergoing Total Hip Arthroplasty | Biotech Hunter | Biotech Hunter